Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Human epidermal growth factor receptor 2 (HER2)-positive tumors are defined by protein overexpression (3+) or gene amplifcation using immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH), respectively.